Academic Journal
Glycopyrronium bromide is a new long-acting anticholinergic drug for the treatment of COPD
| Τίτλος: | Glycopyrronium bromide is a new long-acting anticholinergic drug for the treatment of COPD |
|---|---|
| Συγγραφείς: | S. N. Avdeev, S. Y. Chikina |
| Πηγή: | Медицинский совет, Vol 0, Iss 16, Pp 6-11 (2014) |
| Στοιχεία εκδότη: | Remedium Group LLC, 2014. |
| Έτος έκδοσης: | 2014 |
| Συλλογή: | LCC:Medicine |
| Θεματικοί όροι: | гликопирроний, м-холинорецепторы, хроническая обструктивная болезнь легких, бронходилата-ция, обострения, качество жизни, безопасность, glycopyrronium, m-cholinergic receptors, chronic obstructive pulmonary disease, bronchodilation, exacerbations, quality of life, safety, Medicine |
| Περιγραφή: | Glycopyrronium is a new powerful quick-acting anticholinergic bronchodilator for the treatment of chronic obstructive pulmonary disease. Glycopyrronium is powder in Breezhaler® inhalation device. The review tells about phase III clinical trials demonstrating the positive effect of glycopyrronium on lung function, symptoms of the disease, exercise tolerance, frequency of severe and moderate COPD exacerbations and quality of life of patients. The drug showed good tolerability and high cardiac safety in a long-term period. |
| Τύπος εγγράφου: | article |
| Περιγραφή αρχείου: | electronic resource |
| Γλώσσα: | Russian |
| ISSN: | 2079-701X 2658-5790 |
| Relation: | https://www.med-sovet.pro/jour/article/view/754; https://doaj.org/toc/2079-701X; https://doaj.org/toc/2658-5790 |
| DOI: | 10.21518/2079-701X-2014-16-6-11 |
| Σύνδεσμος πρόσβασης: | https://doaj.org/article/9c05b67237d143108ad94e8fa039e66f |
| Αριθμός Καταχώρησης: | edsdoj.9c05b67237d143108ad94e8fa039e66f |
| Βάση Δεδομένων: | Directory of Open Access Journals |
| ISSN: | 2079701X 26585790 |
|---|---|
| DOI: | 10.21518/2079-701X-2014-16-6-11 |